BARWON HEALTH
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 5K
- Market Cap
- -
Clinical Trials
22
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 120
- Registration Number
- NCT06481163
- Locations
- 🇦🇺
Barwon Health, Geelong, Victoria, Australia
🇦🇺Royal Melbourne Hospital, Melbourne, Australia
A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas
- Conditions
- Gastrointestinal Neuroendocrine Carcinomas
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 4
- Registration Number
- NCT02215447
- Locations
- 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇦🇺Barwon Health, Geelong, Victoria, Australia
🇦🇺Royal Melbourne Hospital, Parkville, Victoria, Australia
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 60
- Registration Number
- NCT01830244
- Locations
- 🇦🇺
Bankstown Lidcome Hospital, Bankstown, New South Wales, Australia
🇦🇺Royal North Shore Hospital, Sydney, New South Wales, Australia
🇦🇺Barwon Health, Geelong, Victoria, Australia
A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 7
- Registration Number
- NCT01486459
- Locations
- 🇦🇺
Barwon Health, Geelong, Victoria, Australia
🇦🇺Peter MacCallum Cancer Centre, Moorabbin, Victoria, Australia
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment
- Conditions
- Prostate Cancer
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 107
- Registration Number
- NCT00823771
- Locations
- 🇦🇺
Andrew Love Cancer Centre, Geelong, Victoria, Australia
- Prev
- 1
- 2
- Next